P38α MAP kinase dimers with swapped activation segments and a novel catalytic loop conformation

Journal of Molecular Biology

Volumn 411, Issue 2, 2011, Pages 474-485

  Rothweiler, Ulli ^a   Åberg, Espen ^a   Johnson, Kenneth A ^a   Hansen, Tom E ^a   Jørgensen, Jorunn B ^a   Engh, Richard A ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

ESRF; European Synchrotron Radiation Facility; MAPK; MAPK kinase; mitogen activated protein kinase; MKK; PDB; Protein Data Bank; SLK; Ste20 like kinase

Indexed keywords

HOMODIMER; MITOGEN ACTIVATED PROTEIN KINASE 14; TYROSINE;

ARTICLE; ATLANTIC SALMON; AUTOPHOSPHORYLATION; DIMERIZATION; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME CONFORMATION; GEL FILTRATION; GEOMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SWAPPED ACTIVATION SEGMENT;

SALMO SALAR;

EID: 79960728952     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.06.013     Document Type: Article

References (41)

1. Manning G.; Whyte D.B.; Martinez R.; Hunter T.; and Sudarsanam S. The protein kinase complement of the human genome Science 298 2002 1912 1934 (Pubitemid 35425239)
2. Lemmon M.A.; and Schlessinger J. Cell signaling by receptor tyrosine kinases Cell 141 2010 1117 1134
3. Sunami T.; Byrne N.; Diehl R.E.; Funabashi K.; Hall D.L.; and Ikuta M. Structural basis of human p70 ribosomal S6 kinase-1 regulation by activation loop phosphorylation J. Biol. Chem. 285 2010 4587 4594
4. Lee S.J.; Cobb M.H.; and Goldsmith E.J. Crystal structure of domain-swapped STE20 OSR1 kinase domain Protein Sci. 18 2009 304 313
5. Pike A.C.; Rellos P.; Niesen F.H.; Turnbull A.; Oliver A.W.; and Parker S.A. Activation segment dimerization: a mechanism for kinase autophosphorylation of non-consensus sites EMBO J. 27 2008 704 714 (Pubitemid 351273130)
6. Katz M.; Amit I.; and Yarden Y. Regulation of MAPKs by growth factors and receptor tyrosine kinases Biochim. Biophys. Acta 1773 2007 1161 1176 (Pubitemid 47125978)
7. Cuenda A.; and Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases Biochim. Biophys. Acta 1773 2007 1358 1375 (Pubitemid 47125981)
8. MAPK: stress responses from molecular mechanisms to therapeutics Trends Mol. Med. 15 2009 369 379
9. Jirmanova L.; Sarma D.N.; Jankovic D.; Mittelstadt P.R.; and Ashwell J.D. Genetic disruption of p38α Tyr323 phosphorylation prevents T-cell receptor-mediated p38α activation and impairs interferon-γ production Blood 113 2009 2229 2237
10. Salvador J.M.; Mittelstadt P.R.; Guszczynski T.; Copeland T.D.; Yamaguchi H.; and Appella E. Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases Nat. Immunol. 6 2005 390 395 (Pubitemid 41716779)
11. Avitzour M.; Diskin R.; Raboy B.; Askari N.; Engelberg D.; and Livnah O. Intrinsically active variants of all human p38 isoforms FEBS J. 274 2007 963 975 (Pubitemid 46204416)
12. Levin-Salomon V.; Maayan I.; Avrahami-Moyal L.; Marbach I.; Livnah O.; and Engelberg D. When expressed in yeast, mammalian mitogen-activated protein kinases lose proper regulation and become spontaneously phosphorylated Biochem. J. 417 2009 331 340
13. Diskin R.; Lebendiker M.; Engelberg D.; and Livnah O. Structures of p38α active mutants reveal conformational changes in L16 loop that induce autophosphorylation and activation J. Mol. Biol. 365 2007 66 76 (Pubitemid 44821197)
14. Mittelstadt P.R.; Yamaguchi H.; Appella E.; and Ashwell J.D. T cell receptor-mediated activation of p38α by mono-phosphorylation of the activation loop results in altered substrate specificity J. Biol. Chem. 284 2009 15469 15474
15. Cuenda A.; Cohen P.; BueeScherrer V.; and Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38) EMBO J. 16 1997 295 305 (Pubitemid 27049387)
16. Kyriakis J.M.; and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol. Rev. 81 2001 807 869 (Pubitemid 32267078)
17. Raingeaud J.; Whitmarsh A.J.; Barrett T.; Derijard B.; and Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway Mol. Cell. Biol. 16 1996 1247 1255
18. Mittelstadt P.R.; Salvador J.S.M.; Fornace A.J.; and Ashwell J.D. Activating p38 MAPK: new tricks for an old kinase Cell Cycle 4 2005 1189 1192 (Pubitemid 41365389)
19. Patel S.B.; Cameron P.M.; O'Keefe S.J.; Frantz-Wattley B.; Thompson J.; and O'Neill E.A. The three-dimensional structure of MAP kinase p38β: different features of the ATP-binding site in p38β compared with p38α Acta Crystallogr.; Sect. D: Biol. Crystallogr. 65 2009 777 785
20. Wilson K.P.; Fitzgibbon M.J.; Caron P.R.; Griffith J.P.; Chen W.; and McCaffrey P.G. Crystal structure of p38 mitogen-activated protein kinase J. Biol. Chem. 271 1996 27696 27700 (Pubitemid 26367339)
21. ter Haar E.; Prabhakar P.; Liu X.; and Lepre C. Crystal structure of the p38α-MAPKAP kinase 2 heterodimer J. Biol. Chem. 282 2007 9733 9739 (Pubitemid 47104583)
22. White A.; Pargellis C.A.; Studts J.M.; Werneburg B.G.; and Farmer B.T. II Molecular basis of MAPK-activated protein kinase 2:p38 assembly Proc. Natl Acad. Sci. USA 104 2007 6353 6358 (Pubitemid 47186098)
23. Alonso-Monge R.; Urena T.; Nombela C.; and Pla J. Functional characterization of human and fungal MAP kinases in Saccharomyces cerevisiae Yeast 24 2007 715 722 (Pubitemid 47412452)
24. Caffrey D.R.; O'Neill L.A.J.; and Shields D.C. The evolution of the MAP kinase pathways: coduplication of interacting proteins leads to new signaling cascades J. Mol. Evol. 49 1999 567 582 (Pubitemid 32268713)
25. Kultz D.; and Burg M. Evolution of osmotic stress signaling via map kinase cascades J. Exp. Biol. 201 1998 3015 3021 (Pubitemid 29006745)
26. Nakagami H.; Pitzschke A.; and Hirt H. Emerging MAP kinase pathways in plant stress signalling Trends Plant Sci. 10 2005 339 346 (Pubitemid 40912457)
27. Imajo M.; Tsuchiya Y.; and Nishida E. Regulatory mechanisms and functions of MAP kinase signaling pathways IUBMB Life 58 2006 312 317 (Pubitemid 43880022)
28. Hansen T.E.; and Jorgensen J.B. Cloning and characterisation of p38 MAP kinase from Atlantic salmon: a kinase important for regulating salmon TNF-2 and IL-1β expression Mol. Immunol. 44 2007 3137 3146 (Pubitemid 46610516)
29. Hansen T.E.; Puntervoll P.; Seternes O.M.; and Jorgensen J.B. Atlantic salmon possess three mitogen activated protein kinase kinase 6 paralogs responding differently to stress FEBS J. 275 2008 4887 4902
30. Brown N.R.; Noble M.E.; Endicott J.A.; and Johnson L.N. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases Nat. Cell Biol. 1 1999 438 443 (Pubitemid 129502811)
31. Zhang J.M.; Yang P.L.; and Gray N.S. Targeting cancer with small molecule kinase inhibitors Nat. Rev.; Cancer 9 2009 28 39
32. Karaman M.W.; Herrgard S.; Treiber D.K.; Gallant P.; Atteridge C.E.; and Campbell B.T. A quantitative analysis of kinase inhibitor selectivity Nat. Biotechnol. 26 2008 127 132
33. Cobb M.H.; and Goldsmith E.J. Dimerization in MAP-kinase signaling Trends Biochem. Sci. 25 2000 7 9 (Pubitemid 30060420)
34. Zhang X.; Gureasko J.; Shen K.; Cole P.A.; and Kuriyan J. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor Cell 125 2006 1137 1149 (Pubitemid 43866200)
35. Littler D.R.; Walker J.R.; Davis T.; Wybenga-Groot L.E.; Finerty P.J.; and Newman E. A conserved mechanism of autoinhibition for the AMPK kinase domain: ATP-binding site and catalytic loop refolding as a means of regulation Acta Crystallogr.; Sect. F: Struct. Biol. Cryst. Commun. 66 2010 143 151
36. Pelech S. Dimerization in protein kinase signaling J. Biol. 5 2006 12
37. Shah N.P.; Tran C.; Lee F.Y.; Chen P.; Norris D.; and Sawyers C.L. Overriding imatinib resistance with a novel ABL kinase inhibitor Science 305 2004 399 401 (Pubitemid 38938156)
38. Tokarski J.S.; Newitt J.A.; Chang C.Y.; Cheng J.D.; Wittekind M.; and Kiefer S.E. The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants Cancer Res. 66 2006 5790 5797 (Pubitemid 43927133)
39. Marcotte D.J.; Liu Y.T.; Arduini R.M.; Hession C.A.; Miatkowski K.; and Wildes C.P. Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases Protein Sci. 19 2010 429 439
40. Williams N.K.; Lucet I.S.; Klinken S.P.; Ingley E.; and Rossjohn J. Crystal structures of the Lyn protein tyrosine kinase domain in its apo- and inhibitor-bound state J. Biol. Chem. 284 2009 284 291
41. Getlik M.; Grutter C.; Simard J.R.; Kluter S.; Rabiller M.; and Rode H.B. Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc J. Med. Chem. 52 2009 3915 3926